 | • レポートコード：MRC2012B1382 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、性感染症（STD）検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。性感染症（STD）検査の種類別市場規模（クラミジア検査、淋病検査、梅毒検査、HIV検査、HSV検査、HPV検査、軟性下疳検査、その他）、用途別市場規模（クリニック、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：BioMerieux、Abbott、F. Hoffmann La Roche、Qiagen、BD、Abbott、Bio-Rad Laboratories、 ・地域別グローバル市場分析 2015年-2020年 ・性感染症（STD）検査の北米市場（アメリカ、カナダ、メキシコ） ・性感染症（STD）検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・性感染症（STD）検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・性感染症（STD）検査の南米市場（ブラジル、アルゼンチン） ・性感染症（STD）検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：クラミジア検査、淋病検査、梅毒検査、HIV検査、HSV検査、HPV検査、軟性下疳検査、その他 ・用途別分析：クリニック、病院、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Sexually Transmitted Diseases Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 89060 million by 2025, from USD 75290 million in 2019.
The Sexually Transmitted Diseases Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sexually Transmitted Diseases Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sexually Transmitted Diseases Testing market has been segmented into:
Chlamydia Testing
Gonorrhea Testing
Syphilis Testing
HIV Testing
HSV Testing
HPV Testing
Chancroid Testing
Other
By Application, Sexually Transmitted Diseases Testing has been segmented into:
Clinics
Hospitals
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sexually Transmitted Diseases Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Sexually Transmitted Diseases Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sexually Transmitted Diseases Testing market.
The report offers in-depth assessment of the growth and other aspects of the Sexually Transmitted Diseases Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sexually Transmitted Diseases Testing Market Share Analysis
Sexually Transmitted Diseases Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sexually Transmitted Diseases Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sexually Transmitted Diseases Testing sales, revenue and market share for each player covered in this report.
The major players covered in Sexually Transmitted Diseases Testing are:
BioMerieux
Abbott
F. Hoffmann La Roche
Qiagen
BD
Abbott
Bio-Rad Laboratories
Table of Contents
1 Sexually Transmitted Diseases Testing Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Diseases Testing
1.2 Classification of Sexually Transmitted Diseases Testing by Type
1.2.1 Global Sexually Transmitted Diseases Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sexually Transmitted Diseases Testing Revenue Market Share by Type in 2019
1.2.3 Chlamydia Testing
1.2.4 Gonorrhea Testing
1.2.5 Syphilis Testing
1.2.6 HIV Testing
1.2.7 HSV Testing
1.2.8 HPV Testing
1.2.9 Chancroid Testing
1.2.10 Other
1.3 Global Sexually Transmitted Diseases Testing Market by Application
1.3.1 Overview: Global Sexually Transmitted Diseases Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Sexually Transmitted Diseases Testing Market by Regions
1.4.1 Global Sexually Transmitted Diseases Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sexually Transmitted Diseases Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sexually Transmitted Diseases Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sexually Transmitted Diseases Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexually Transmitted Diseases Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sexually Transmitted Diseases Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexually Transmitted Diseases Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 BioMerieux
2.1.1 BioMerieux Details
2.1.2 BioMerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 BioMerieux SWOT Analysis
2.1.4 BioMerieux Product and Services
2.1.5 BioMerieux Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott SWOT Analysis
2.2.4 Abbott Product and Services
2.2.5 Abbott Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 F. Hoffmann La Roche
2.3.1 F. Hoffmann La Roche Details
2.3.2 F. Hoffmann La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 F. Hoffmann La Roche SWOT Analysis
2.3.4 F. Hoffmann La Roche Product and Services
2.3.5 F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen
2.4.1 Qiagen Details
2.4.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen SWOT Analysis
2.4.4 Qiagen Product and Services
2.4.5 Qiagen Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 BD
2.5.1 BD Details
2.5.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 BD SWOT Analysis
2.5.4 BD Product and Services
2.5.5 BD Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Abbott
2.6.1 Abbott Details
2.6.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Abbott SWOT Analysis
2.6.4 Abbott Product and Services
2.6.5 Abbott Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio-Rad Laboratories
2.7.1 Bio-Rad Laboratories Details
2.7.2 Bio-Rad Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio-Rad Laboratories SWOT Analysis
2.7.4 Bio-Rad Laboratories Product and Services
2.7.5 Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sexually Transmitted Diseases Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexually Transmitted Diseases Testing Players Market Share
3.2.2 Top 10 Sexually Transmitted Diseases Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sexually Transmitted Diseases Testing Revenue and Market Share by Regions
4.2 North America Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
4.5 South America Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
5 North America Sexually Transmitted Diseases Testing Revenue by Countries
5.1 North America Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
5.2 USA Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
6 Europe Sexually Transmitted Diseases Testing Revenue by Countries
6.1 Europe Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
6.2 Germany Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
6.3 UK Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
6.4 France Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sexually Transmitted Diseases Testing Revenue by Countries
7.1 Asia-Pacific Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
7.2 China Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
7.5 India Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
8 South America Sexually Transmitted Diseases Testing Revenue by Countries
8.1 South America Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
8.2 Brazil Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sexually Transmitted Diseases Testing by Countries
9.1 Middle East & Africa Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sexually Transmitted Diseases Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Sexually Transmitted Diseases Testing Market Forecast by Type (2019-2024)
10.3 Chlamydia Testing Revenue Growth Rate (2015-2025)
10.4 Gonorrhea Testing Revenue Growth Rate (2015-2025)
10.5 Syphilis Testing Revenue Growth Rate (2015-2025)
10.6 HIV Testing Revenue Growth Rate (2015-2025)
10.7 HSV Testing Revenue Growth Rate (2015-2025)
10.8 HPV Testing Revenue Growth Rate (2015-2025)
10.9 Chancroid Testing Revenue Growth Rate (2015-2025)
10.10 Other Revenue Growth Rate (2015-2025)
11 Global Sexually Transmitted Diseases Testing Market Segment by Application
11.1 Global Sexually Transmitted Diseases Testing Revenue Market Share by Application (2015-2020)
11.2 Sexually Transmitted Diseases Testing Market Forecast by Application (2019-2024)
11.3 Clinics Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Sexually Transmitted Diseases Testing Market Size Forecast (2021-2025)
12.1 Global Sexually Transmitted Diseases Testing Market Size Forecast (2021-2025)
12.2 Global Sexually Transmitted Diseases Testing Market Forecast by Regions (2021-2025)
12.3 North America Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
12.4 Europe Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
12.6 South America Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sexually Transmitted Diseases Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sexually Transmitted Diseases Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sexually Transmitted Diseases Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sexually Transmitted Diseases Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. BioMerieux Corporate Information, Location and Competitors
Table 6. BioMerieux Sexually Transmitted Diseases Testing Major Business
Table 7. BioMerieux Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 8. BioMerieux SWOT Analysis
Table 9. BioMerieux Sexually Transmitted Diseases Testing Product and Solutions
Table 10. BioMerieux Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Abbott Corporate Information, Location and Competitors
Table 12. Abbott Sexually Transmitted Diseases Testing Major Business
Table 13. Abbott Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2018-2019)
Table 14. Abbott SWOT Analysis
Table 15. Abbott Sexually Transmitted Diseases Testing Product and Solutions
Table 16. Abbott Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. F. Hoffmann La Roche Corporate Information, Location and Competitors
Table 18. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Major Business
Table 19. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 20. F. Hoffmann La Roche SWOT Analysis
Table 21. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Product and Solutions
Table 22. F. Hoffmann La Roche Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Qiagen Corporate Information, Location and Competitors
Table 24. Qiagen Sexually Transmitted Diseases Testing Major Business
Table 25. Qiagen Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 26. Qiagen SWOT Analysis
Table 27. Qiagen Sexually Transmitted Diseases Testing Product and Solutions
Table 28. Qiagen Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. BD Corporate Information, Location and Competitors
Table 30. BD Sexually Transmitted Diseases Testing Major Business
Table 31. BD Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 32. BD SWOT Analysis
Table 33. BD Sexually Transmitted Diseases Testing Product and Solutions
Table 34. BD Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Abbott Corporate Information, Location and Competitors
Table 36. Abbott Sexually Transmitted Diseases Testing Major Business
Table 37. Abbott Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 38. Abbott SWOT Analysis
Table 39. Abbott Sexually Transmitted Diseases Testing Product and Solutions
Table 40. Abbott Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 42. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Major Business
Table 43. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Total Revenue (USD Million) (2017-2018)
Table 44. Bio-Rad Laboratories SWOT Analysis
Table 45. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Product and Solutions
Table 46. Bio-Rad Laboratories Sexually Transmitted Diseases Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Sexually Transmitted Diseases Testing Revenue (Million USD) by Players (2015-2020)
Table 48. Global Sexually Transmitted Diseases Testing Revenue Share by Players (2015-2020)
Table 49. Global Sexually Transmitted Diseases Testing Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Sexually Transmitted Diseases Testing Revenue Market Share by Regions (2015-2020)
Table 51. North America Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
Table 52. North America Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Table 53. Europe Sexually Transmitted Diseases Testing Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Sexually Transmitted Diseases Testing Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Sexually Transmitted Diseases Testing Revenue by Countries (2015-2020)
Table 56. South America Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Sexually Transmitted Diseases Testing Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Table 59. Global Sexually Transmitted Diseases Testing Revenue (Million USD) by Type (2015-2020)
Table 60. Global Sexually Transmitted Diseases Testing Revenue Share by Type (2015-2020)
Table 61. Global Sexually Transmitted Diseases Testing Revenue Forecast by Type (2021-2025)
Table 62. Global Sexually Transmitted Diseases Testing Revenue by Application (2015-2020)
Table 63. Global Sexually Transmitted Diseases Testing Revenue Share by Application (2015-2020)
Table 64. Global Sexually Transmitted Diseases Testing Revenue Forecast by Application (2021-2025)
Table 65. Global Sexually Transmitted Diseases Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sexually Transmitted Diseases Testing Picture
Figure 2. Global Sexually Transmitted Diseases Testing Revenue Market Share by Type in 2019
Figure 3. Chlamydia Testing Picture
Figure 4. Gonorrhea Testing Picture
Figure 5. Syphilis Testing Picture
Figure 6. HIV Testing Picture
Figure 7. HSV Testing Picture
Figure 8. HPV Testing Picture
Figure 9. Chancroid Testing Picture
Figure 10. Other Picture
Figure 11. Sexually Transmitted Diseases Testing Revenue Market Share by Application in 2019
Figure 12. Clinics Picture
Figure 13. Hospitals Picture
Figure 14. Other Picture
Figure 15. Global Sexually Transmitted Diseases Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Sexually Transmitted Diseases Testing Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Sexually Transmitted Diseases Testing Revenue Market Share in 2019
Figure 24. Global Top 10 Players Sexually Transmitted Diseases Testing Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Sexually Transmitted Diseases Testing Revenue Market Share by Regions (2015-2020)
Figure 28. Global Sexually Transmitted Diseases Testing Revenue Market Share by Regions in 2018
Figure 29. North America Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 30. Europe Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 32. South America Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 34. North America Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Figure 35. North America Sexually Transmitted Diseases Testing Revenue Market Share by Countries in 2019
Figure 36. USA Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 37. Canada Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 39. Europe Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Sexually Transmitted Diseases Testing Revenue Market Share by Countries in 2019
Figure 41. Germany Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 42. UK Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 43. France Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 44. Russia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 45. Italy Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Sexually Transmitted Diseases Testing Revenue Market Share by Countries in 2019
Figure 48. China Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 49. Japan Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 50. Korea Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 51. India Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 53. South America Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Figure 54. South America Sexually Transmitted Diseases Testing Revenue Market Share by Countries in 2019
Figure 55. Brazil Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 60. UAE Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Sexually Transmitted Diseases Testing Revenue and Growth Rate (2015-2020)
Figure 63. Global Sexually Transmitted Diseases Testing Revenue Share by Type (2015-2020)
Figure 64. Global Sexually Transmitted Diseases Testing Revenue Share by Type in 2019
Figure 65. Global Sexually Transmitted Diseases Testing Market Share Forecast by Type (2021-2025)
Figure 66. Global Chlamydia Testing Revenue Growth Rate (2015-2020)
Figure 67. Global Gonorrhea Testing Revenue Growth Rate (2015-2020)
Figure 68. Global Syphilis Testing Revenue Growth Rate (2015-2020)
Figure 69. Global HIV Testing Revenue Growth Rate (2015-2020)
Figure 70. Global HSV Testing Revenue Growth Rate (2015-2020)
Figure 71. Global HPV Testing Revenue Growth Rate (2015-2020)
Figure 72. Global Chancroid Testing Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global Sexually Transmitted Diseases Testing Revenue Share by Application (2015-2020)
Figure 75. Global Sexually Transmitted Diseases Testing Revenue Share by Application in 2019
Figure 76. Global Sexually Transmitted Diseases Testing Market Share Forecast by Application (2021-2025)
Figure 77. Global Clinics Revenue Growth Rate (2015-2020)
Figure 78. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 79. Global Other Revenue Growth Rate (2015-2020)
Figure 80. Global Sexually Transmitted Diseases Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Sexually Transmitted Diseases Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Sexually Transmitted Diseases Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
Figure 84. Europe Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
Figure 86. South America Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Sexually Transmitted Diseases Testing Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
性感染症（STD）診断の世界市場（～2026年） Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses. Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of a…- 性感染症（STD）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Sexually Transmitted Disease (STD ) Drug Market The global Sexually Transmitted Disease (STD ) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Sexually Transmitted Disease (STD…
- 動物用自己免疫疾患検査の世界市場（～2026年） Animal autoimmune diseases are the result of specific immune responses and directed against self. Animals have the ability to control immune aggression. It acquired the capacity to avoid self-reaction called as tolerance, which allows removal of antigenic pathogens in the absence of self-recognition…
- 病院用微生物検査の世界市場（～2026年） Hospital microbiology testing is a part of clinical laboratory testing involved in conducting multiple tests and blood collections in hospitals. It enables adequate management of threats of infectious diseases. Global hospital microbiology testing market is expected to witness lucrative growth over …
- 梅毒検査の世界市場（～2026年） Syphilis is one of the vital sexually transmitted infections (STIs) caused by the bacteria named, Treponema pallidum, and can lead to long-term complications, if not diagnosed adequately. The latest trend gaining momentum in the market is increase in premarital screening. Premarital screening is a h…